Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Apply
Tafasitamab, Rituximab, Lenalidomide
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step